Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Urol Oncol. 2020 Jul 13;38(9):734.e1–734.e10. doi: 10.1016/j.urolonc.2020.05.015

Figure IV:

Figure IV:

Median overall survival is poor among Veterans with metastatic prostate cancer at the time of diagnosis. Even among patients with metastatic disease, median estimated life expectancy decreases with increasing age and increasing number of comorbid conditions. (A) The median overall survival is shown by age and number of comorbidities. (B) A heatmap illustrates median life expectancy with red coloring representing less than 2 years and green coloring representing four or more years.